Medidata Medidata


A Statement from our Co-Founders and Co-CEOs Glen de Vries and Tarek Sherif

Your Research Brings Hope To Millions of Patients. Our Platform Accelerates it.

SHYFT Analytics, the leading commercial analytics and real world evidence platform for the life sciences industry is now part of Acorn AI

The Impact of COVID-19 on Clinical Trial Sites

Medidata surveyed over 1,000 sites to see how the COVID-19 pandemic is affecting their ability to start, conduct and complete clinical studies.

Stay informed: Medidata’s customer commitment during COVID-19 (Learn more)

COVID-19 and Clinical Trials: The Medidata Perspective

Release 7.0

As the global impact of COVID-19 increases, Medidata is continuously analyzing its effect on patient study enrollment, the response by world regulatory bodies and which Medidata’s solutions can help address your COVID 19-related challenges.

[Virtual Event] World Orphan Drug Congress

August 24 - 26, 2020

Medidata is participating in the upcoming World Orphan Drug Congress as a sponsor and a thought leader. Visit our sponsor page to download content and learn how Medidata is uniquely positioned to help bring more rare disease therapies to market, overcoming challenges in clinical development.

Don’t miss our dynamic thought leadership roundtable discussion “Rare Diseases – Leveraging Data to Address Patient Scarcity in Clinical Trials.” Medidata’s Sheila Diamond, MS, CGC, Scientific Business Development Director, and Alicia Staley, Senior Director, Patient Engagement, will discuss the challenges around patient scarcity in rare disease clinical trials and how data and advanced analytics can help mitigate them. (Wednesday, August 26 @ 2:10 pm)

Help Us Power Technology That Changes Lives